Cellana is a leading developer of algae-based bioproducts, and its pre-commercial production of marine microalgae takes place at Cellana?s Kona Demonstration Facility (KDF) in Hawaii. KDF is housing more than 70 high-performing algal strains for different bioproducts, of which over 30 have been grown outside at scale. So far, Cellana has produced more than 10 metric tons of algal biomass for the development of biofuels, animal feed, and high-value nutraceuticals. Cellana?s ALDUO algal cultivation technology allows Cellana to grow non-extremophile algal strains at large scale with no contamination disruptions. Cellana?s research and production at KDF have addressed three major areas that are crucial for the commercialization of algal biofuels: yield improvement, cost reduction, and the overall economics. Commercially acceptable solutions have been developed and tested for major factors limiting areal productivity of algal biomass and lipids based on years of R&D work conducted at KDF. Improved biomass and lipid productivity were achieved through strain improvement, culture management strategies (e.g., alleviation of self-shading, de-oxygenation, and efficient CO2 delivery), and technical advancement in downstream harvesting technology. Cost reduction was achieved through optimized CO2 delivery system, flue gas utilization technology, and energy-efficient harvesting technology. Improved overall economics was achieved through a holistic approach by integration of high-value co-products in the process, in addition to yield improvements and cost reductions.